, Helen Bygrave h and David Maman a A multicentric, retrospective case-series analysis (facility-based) in five sites across Kenya, Malawi, Mozambique, and Uganda screened HIV-positive adults for hepatitis C virus (HCV) antibodies using Oraquick rapid testing and viral confirmation (in three sites). The results reveal a substantially lower prevalence than previously reported for these countries, suggesting that targeted integration of HCV screening in African HIV programs may be more impactful than routine screening.
Prior research on hepatitis C virus (HCV) infection in sub-Saharan Africa is limited and methodologically inconsistent, often characterized by poor categorization of individuals from high-risk groups, lack of virological confirmation of active disease, and bias from environmental factors (e.g. reduced case detection specificity from Schistosoma) [1] [2] [3] [4] . Furthermore, reported HCV co-infection prevalence is highly variable in Africa, ranging from 3.3% in southern regions to 42.3% in the north.
We conducted a retrospective case-series analysis in health facilities and hospitals in five African countries with varied HIV prevalence settings, the largest observational analysis of HIV/HCV co-infection in Africa to date. Table 1 .
HCV-antibody and PCR-positivity prevalence measured in our study were substantially lower than pooled estimates from other studies conducted in the same five countries [1] , neighboring African countries, and other low-resource contexts [13] [14] [15] . This may be explained by a number of differences unique to our study: patient characteristics (e.g. exclusively HIV-infected patients, PWUD); differences in screening strategies; or variation in the performance of serological rapid diagnostic tests (e.g. Oraquick was the only WHO-prequalified rapid diagnostic test (RDT) at the time of study, it has not been widely tested in field situations in African settings or in HIV-infected populations [16, 17] ).
There was some variation between our sample sites. The Mozambican PWUD sub-group observed the highest levels of antibody-prevalence and viral confirmation, confirming that even when prevalence is low, PWUD are especially susceptible to HCV infection and may require targeted screening. In Uganda, viral genotyping revealed exclusively Type 4 HCV, diverging from previous evidence finding only Type 1 in the country [1, 18] . Linked with choice of regimen, the difference is important, whereas research on this issue is evolving and few data are available overall. In addition, sex differences between sites (high proportion of women in Ugandan HCV-confirmed patients, high proportion of men in Mozambican HCVconfirmed patients) were likely because of gendered risk behaviors, such as injection drug use.
There were some limitations in this study. Except for the Mozambican PWUD, these patients may not have had HCV risk factors. Database limitations prevented analysis of a potential cohort effect when individuals had already died. Information on co-infection with HCV and Schistosomiasis was unavailable, though prior literature has suggested causes of a high HCV false positivity screening percentage in these moderate-to-high Schistosoma-prevalent countries. Statistical variance ('falsepositive paradox') may have led to more false-positive results compared with true positives when low incidence rates were lower than false-positive rates [3, 19, 20] .
In summary, our results not only demonstrate the feasibility of large-scale HCV screening during HIV care using simplified rapid testing, but also confirm that HCV does not seem to be the public health burden in the sites investigated that it is in other regions, particularly among people living with HIV. Future HCV screening strategies in the region should consider these findings when determining policy (MSF has already replaced systematic HCV screening for HIV-positive patients at study sites with a risk factor and symptomatic screening algorithm, prioritizing PWUD). Policy changes will be more efficient if they also increase access to testing and treatment. 
